Systemic mycoses in renal transplant recipients
Abstract
Системные (глубокие оппортунистические) микозы являются одним из самых серьезных, хотя и не самых частых, инфекционных осложнений после трансплантации почки. При глубоких оппортунистических микозах, развивающихся в условиях иммунодефицита, поражаются внутренние органы и глубоко лежащие ткани. Грибковые инфекции у реципиентов почечного трансплантата можно условно разделить на 2 группы. Это, во-первых, эндемичные системные микозы, встречающиеся в определенных географических регионах (гистоплазмоз, бластомикоз, кокцидиомикоз, паракокцидиомикоз), и во-вторых - оппортунистические грибковые инфекции, возбудители которых редко вызывают инвазивное заболевание у лиц с нормальным иммунитетом (аспергиллез, кандидоз, криптококкоз, мукороз и др.) [95]. Наиболее часто возбудителями системных микозов у больных после ТП являются Candida spp. и Aspergillus spp., существенное значение имеет также Cryptococcus [28, 54, 93, 105]. В ряде случаев у реципиентов РТ развиваются более редкие грибковые заболевания - зигомикоз (в том числе - мукороз), моноспоридиоз, сцедоспориоз, феогифомикоз и др. [10, 11, 38]. Кроме того, возбудитель тяжелой легочной инфекции Pneumocystis carinii относится к атипичным микрогрибам, поэтому в современных руководствах пневмоцистоз описывается в разделе грибковых инфекций [4, 32].
About the Author
E. I. Prokopenko
ГУ Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского, г. Москва
Russian Federation
Russian Federation
References
1. Бурова С.А., Курбатова И.В. Лабораторная диагностика оппортунистических системных микозов. Успехи медицинской микологии. Материалы первого Всероссийского конгресса по медицинской микологии. М.: 2003; 2: 220-221.
2. Клясова Г.А., Петрова Н.А., Толкачева Т.В. и др. Лечение итраконазолом в суспензии орофарингеального кандидоза у иммуноскомпрометированных больных. Гематология 2003; 11: 18-24.
3. Никифорова З.Н., Шевченко В.Е., Щербаков С.Д. и др. Действие гранулоцитарно-макрофагального колониестимулирующего фактора на антикандидозную активность нейтрофилов у онкогематологических больных. Успехи медицинской микологии. Материалы первого Всероссийского конгресса по медицинской микологии. М.: 2003; 2: 262-263.
4. Руководство по трансплантации почки. Под ред. Данович Г.М., пер. с англ. под ред. Мойсюка Я.Г. 3-е изд. Тверь: Триада 2004: 472 с.
5. Сергеев А.Ю. Эволюция антимикотиков и революция в терапии микозов. Успехи медицинской микологии. Материалы первого Всероссийского конгресса по медицинской микологии. М.: 2003; 2: 111-112.
6. Сергеев А.Ю., Сергеев Ю.В. Грибковые инфекции. Руководство для врачей. М.: Бином-пресс 2003: 440 с.
7. Филатов Л.Б. Стратегия и тактика минимизации риска развития острой почечной недостаточности в результате лечения амфотерицином B. Успехи медицинской микологии. Материалы первого Всероссийского конгресса по медицинской микологии. М.: 2003; 2: 230-233.
8. Abbott K.C., Hypolite I., Poropatich R.K. et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 2001; 3(4): 203-211.
9. Ahmed J., Ditmars D.M., Sheppard T. et al. Recurrence of Scedosporium apiospermum infection following renal retransplantation. Am J Transplant 2004; 4(10): 1720-1724.
10. Al Soub H., El Deeb Y., Almaslaman I.M., Al Khuwaiter J.Y. Zygomycosis in Qatar: a retrospective review of six cases. Allerg Immunol (Paris) 2004; 36(10): 387-391.
11. Al-Abdely H.M., Alkhunaizi A.M., Al-Tawfiq J.A. et al. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med Mycol 2005; 43(1): 91-95.
12. Alexander B.D. Diagnosis of fungal infection: new technologies for the mycology laboratory. Transpl Infect Dis 2002; 4 Suppl 3: 32-37.
13. Aliff T.B., Maslak P.G., Jurcic J.G. et al. Aspergiiillus pneumonia in patient with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. 43rd annual meeting of American Society of Hematology (Orlando, Florida) 2001; Abstract 1381.
14. Altiparmak M.R., Apaydin S., Trablus S. Systemic fungal infections after renal transplantation. Scand J Infect Dis 2002; 34(4): 284-288.
15. Anaissie E.J., Stratton S.L., Dignani M.C. et al. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 2002; 34(6): 780-789.
16. Anttila V.J., Piilonen A., Valtonen M. et al. Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection. Scand J Infect Dis 2003; 35(11-12): 893-894.
17. Arathoon E.G., Gotuzzo E., Noriega L.M. et al. Randomized, double-blind, multicenter study of Caspofungin versus amphotericin Bfor treatment of oropharyngeal and esophageal candidiasis. Antimicrob Agents Chemother 2002; 46: 451-457.
18. Arikan S., Lozano-Chiu M., Paetznick V., Rex J.H. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother 2002; 46: 245-247.
19. Azevedo L.S., Castro M.C., Paula F.J. et al. Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients. Rev Inst Med Trop Sao Paulo 2005; 47(3): 143-145.
20. Basaran O., Emiroglu R., Arikan U. et al. Cryptococcal necrotizing fasciitis with multiple sites of involvement in the lower extremities. Dermatol Surg 2003; 29(11): 1158-1160.
21. Battaglia M., Ditonno P., Selvaggio O. et al. Kidney transplants from infected donors: our experience. Transplant Proc 2004; 36(3): 491-492.
22. Beck J.M., Harmsen A.G. Lymphocytes in host defense against Pneumocystis carinii. Semin Respir Infect 1998; 13(4): 330-338.
23. Blair J.E. Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation. Transpl Infect Dis 2004; 6(2): 74-76.
24. Blin N., Morineau N., Gaillard F., Morin O. et al. Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma. Leuk Lymphoma 2004; 45(10): 2161-2163.
25. Branten A.J., Beckers P.J., Tiggeler R.G., Hoitsma A.J. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol Dial Transplant 1995; 10: 1194-1197.
26. Campagnaro E.L., Woodside K.J, Early M.G. et al. Disseminated Pseudallescheria boydii (Scedosporium apiospermum) infection in a renal transplant patient. Transpl Infect Dis 2002; 4(4): 207-211.
27. Coates M., Wilson J. Central nervous system aspergillus infection complicating renal transplantation. Australas Radiol 2001; 45(3): 338-342.
28. Colomba C., Antinori S. Fungal infections in transplantation patients. Recenti Prog Med 2003; 94(11): 516-528.
29. Costa C., Costa J.M., Desterke C. et al. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2002; 40: 2224-2227.
30. Crompton J.A., Alexander D., Somerville T., Shihab F.S. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient. Transpl Infect Dis 2004; 6(4): 183-187.
31. David S.M. Making best use of the newer antifungal drugs. Infect Med 2003; 20: 392-399.
32. Dei-Cas E. Pneumocystis infections: the iceberg? Med Mycol 2000; 38 Suppl 1: 23-32.
33. Denning D.W., Dupont B., Pauw B. Invasive fungal infection. London: Royal Society of Medicine Press 1999: 386 p.
34. Denning D.W., Evans E.G., Kibbler C.C. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis 1997; 16(6): 424-436.
35. Derici U., Ayerdem F., Arinsoy T. et al. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient. Haematologia (Budap) 2002; 32(4): 557-560.
36. Dominiguez J., Mahalati K., Kiberd B. et al. Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. Transplantation 2000; 70: 1244-1247.
37. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.1 Late infections. Pneumocystis carinii pneumonia. Nephrol Dial Transplant 2002; 17 Suppl 4: 36-39.
38. Echo A., Hovsepian R.V., Shen G.K. Localized cecal zygomycosis following renal transplantation. Transpl Infect Dis 2005; 7(2): 68-70.
39. Elzi L., Laifer G., Bremeric G., Vosbeck J., Mair M. Invasive aspergillosis with myocardial involvement after kidney transplantation. NDT 2005; 20: 631-634.
40. Ergin F., Arslan H., Azap A. et al. Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature. Transpl Int 2003; 16: 280-286.
41. Feinberg J. Pneumocystis carinii pneumonia. In: Goldman L., Bennet J.C., eds Cecil Textbook of Medicine, 21 st edn. 2000; 1877-1883.
42. Flahaut M., Sanglard D., Monod M. et al. Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J Clin Microbiol 1998; 36(2): 395-401.
43. Florea N.R., Capitano B., Nightingale C.H. et al. Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients. Transplant Proc 2003; 35(8): 2873-2877.
44. Gari-Toussaint M., Ngoc L.H., Gigante M. et al. Kidney transplant and Candida albicans arteritis. The importance of analysing the transplant conservation liquid. Presse Med 2004; 33(13): 866-868.
45. Garrido J., Labrador P.J., Lerma L. et al. Vascular Aspergillus infection in two recipients of kidneys from the same donor. Nefrologia 2004; 24 Suppl 3: 30-34.
46. Gordon S.M., LaRosa S.P., Kalmadi S. et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999; 28: 240-246.
47. Guermazi A., Benchaib N., Zagdanski A.M. et al. Cerebral and spinal cord involvement resulting from invasive aspergillosis. Eur Radiol 2002; 12(1): 147-150.
48. Gupta R.K., Khan Z.U., Nampoory M.R. et al. Cutaneous cryptococcosis in a diabetic renal transplant recipient. J Med Microbiol 2004; 53(Pt 5): 445-449.
49. Gupta S., Dash S.C., Sharma S. et al. Pneumocystis carinii pneumonia: role of high resolution computed tomography. J Assoc Physicians India 2002; 50(5): 726-728.
50. Hagerty J.A., Ortiz J., Reich D., Manzarbeitia C. Fungal infections in solid organ transplant patients. Surg Infect (Larchmt) 2003; 4(3): 263-271.
51. Haight D.O., Esperanza L.E., Greene J.N. et al. Case report: cutaneous manifestations of cryptococcosis. Am J Med Sci 1994; 308(3): 192-195.
52. Herbrecht R., Denning D.W., Patterson T.F. et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415.
53. Herbrecht R., Zamfir A., Letscher-Bru V. Visceral candidiasis. Rev Prat 2001; 51(7): 725-730.
54. Hibberd P.L., Rubin R.H. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994; 19 Suppl 1: S33-40.
55. High K.P., Washburn R.G. Invasive aspergillosis in mice immunosuppressed with cyclosporine A, tacrolimus (FK506) or sirolimus (rapamycin). J Infect Dis 1977; 175: 222-225.
56. Hiyoshi M., Tagawa S., Hashimoto S. et al. Evaluation of a new laboratory test measuring plasma (1-->3)-beta-D-glucan in the diagnosis of Candida deep mycosis: comparison with a serologic test. Kansenshogaku Zasshi 1999; 73(1): 1-6.
57. Jha V., Chugh K.S. Posttransplant infections in the tropical countries. Artif Organs 2002; 26(9): 770-777.
58. John G.H., Shankar V., Talaulicar G. et al. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation 2003; 75: 1544-1551.
59. Kim S.W., Nah M.Y., Yeum C.H. et al. Pelvic aspergillosis with tubo-ovarian abscess in a renal transplant recipient. J Infect 2001; 42(3): 215-217.
60. Kontoyiannis D.P., Hachen R., Lewis R.E. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients hematologic malignancies. Cancer 2003; 98: 292-299.
61. Ladurner R., Brandacher G., Steurer W. et al. Lessons to be learned from a complicated case of rhino-cerebral mucormycosis in a renal allograft recipient. Transpl Int 2003; 16(12): 885-889.
62. Le Moing V., Lortholary O., Timsit J.F. et al. Aspergillus pericarditis: report of a successfully treated case with tamponade and literature review. Clin Infect Dis 1998; 26: 451-460.
63. Lee Y.A., Kim H.J., Lee T.W. et al. First report of Cryptococcus albidus-induced disseminated cryptococcosis in a renal transplant recipient. Korean J Intern Med 2004; 19(1): 53-57.
64. Lin S.J., Schranz J., Teutsch S.M. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-366.
65. Luff V., Kliem V., Behrend M. et al. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation 1996; 62: 421-423.
66. Maertens J., Verhaegen J., Lagrou K. et al. Screening of circulating galactomannan as noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem sell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610.
67. Maesaki S. Serodiagnosis for deep-seated mycoses. Nippon Ishinkin Gakkai Zasshi 2002; 43(4): 233-237.
68. Mennink-Kersten M.A., Donnelly J.P., Verweij P.E. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349-357.
69. Morgenstern G.R., Prentice A.G., Prentice H.G. et al. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with hematological malignancies. Br J Hematol 1999; 105: 901-911.
70. Mueller N.J., Fishman J.A. Asymptomatic pulmonary cryptococcosis in solid organ transplantation: report of four cases and review of the literature. Transpl Infect Dis 2003; 5(3): 140-143.
71. Ndimbie O.K., Dekker A., Martinez A.J., Dixon B. Prostatic sequestration of Cryptococcus neoformans in immunocompromised persons treated for cryptococcal meningoencephalitis. Histol Histopathol 1994; 9(4): 643-648.
72. Neuville S., Dromer F., Chretien F. et al. Physiopathology of meningoencephalitis caused by Cryptococcus neoformans. Ann Med Interne (Paris) 2002; 153(5): 323-328.
73. Nosanchuk J.D., Shoham S., Fries B.C. et al. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med 2000; 132(3): 205-208.
74. O'Gara M.J., Lee C.H., Weinberg G.A. et al. IMP dehydrogenase from Pneumocystis carinii as a potential drug target. Antimicrob Agents Chemother 1997; 41: 40-48.
75. Pai M., Allen S. Voriconazole inhibition of tacrolimus metabolism. Clin Infect Dis 2003; 36: 1089-1091.
76. Panackal A.A., Dahlman A., Keil K.T. et al. Outbreak of invasive aspergillosis among renal transplant recipients. Transplantation 2003; 75(7): 1050-1053.
77. Paterson D.L., Singh N. Invasive aspergillosis in transplant recipients. Medicine 1999; 78: 123-138.
78. Quinio D., Karam A., Leroy J.P. et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med Mycol 2004; 42(2): 177-180.
79. Rabodonirina M., Vanhems P., Couray-Targe S. et al. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. Emerg Infect Dis 2004; 10(10): 1766-1773.
80. Radisic M., Lattes R., Chapman J.F. et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis 2003; 5(2): 84-93.
81. Reichenberger F., Dickenmann M., Binet I. et al. Diagnostic yield of bronchoalveolar lavage following renal transplantation. Transpl Infect Dis 2001; 3(1): 2-7.
82. Rocamora N., Tormo A.M., Franco A. et al. Fever and cavitary infiltrate in a renal transplant recipient. Nefrologia 2004; 24 Suppl 3: 16-20.
83. Salvalaggio P.R., Bassetti M., Lorber M.I. et al. Aspergillus vertebral osteomyelitis after simultaneous kidney-pancreas transplantation. Transpl Infect Dis 2003; 5(4): 187-190.
84. Sanati H., Belanger P., Fratti B., Ghannoum M. A new triazole, voriconazole (Uk-09, 496), blocks sterol biosyntheis in Candida albicans and Candida krusei. Antimicrob Agents Chemother 1997; 41: 2492-2496.
85. Scanagatta P., Terzi A., Boschiero L. et al. Invasive pulmonary aspergillosis after renal transplantation treated by surgery. Asian Cardiovasc Thorac Ann 2004; 12(1): 83-85.
86. Schelenz S., Goldsmith D.J. Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients. J Infect 2003; 47(4): 336-343.
87. Schmidt S., Reiter-Owona I., Hotz M. et al. An unusual case of central nervous system cryptococcosis. Clin Neurol Neurosurg 1995; 97(1): 23-27.
88. Shorr A.F., Susla G.M., O'Grady N.P. Pulmonary infiltrates in the non-HIV-infected immunocompromised patients: etiologies, diagnostic strategies, and outcomes. Chest 2004; 125: 260-271.
89. Singh H., Heitman J. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycosis in organ transplant recipients. Transplantation 2004; 77: 795-800.
90. Singh N., Gayowski T., Wagener M.M. et al. Invasive fungal infections in renal transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997; 24: 179-185.
91. Summers S.A., Dorling A., Boyle J.J., Shaunak S. Cure of disseminated cryptococcal infection in a renal allograft recipient after addition of gamma-interferon to anti-fungal therapy. Am J Transplant 2005; 5(8): 2067-2069.
92. Sung S.A., Ko G.J., Kim J.Y. et al. Desquamative interstitial pneumonia associated with concurrent cytomegalovirus and Aspergillus pneumonia in a renal transplant recipient. Nephrol Dial Transplant 2005; 20: 635-638.
93. Takahashi K. Mycosis in kidney transplant patients. Nippon Ishinkin Gakkai Zasshi 2001; 42(4): 201-204.
94. Tintillier V., Kirch L., Goffin E. et al. Interaction between voriconazole and tacrolimus in a kidney-transplanted patients. Nephrol Dial Transplant 2005; 20: 664-665.
95. Tolkoff-Rubin N.E., Rubin R.H. Opportunistic fungal and bacterial infection in the renal transplant recipient. J Am Soc Nephrol 1992; 2(12 Suppl): S264-269.
96. Tolkoff-Rubin N.E., Rubin R.H. Recent advances in the diagnosis and management of infection in the organ transplant recipient. Semin Nephrol 2000; 20(2): 148-163.
97. Vaideeswar P., Prasad S., Deshpande J.R., Pandit S.P. Invasive pulmonary aspergillosis: A study of 39 cases at autopsy. J Postgrad Med 2004; 50(1): 21-26.
98. Vargas S.L., Ponce C.A., Gigliotti F. et al. Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol 2000; 38(4): 1536-1538.
99. Venkataramanan R., Zang S., Gayowski T., Singh N. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in liver microsomes. Antimicrob Agents Chemother 2002; 46: 3091-3093.
100. Villanueva A., Arathoon E.G., Gotuzzo E. et al. A randomized double-blind study of Caspofungin versus fluconazole for treatment of esophageal candidiasis. Am J Med 2002; 113: 294-299.
101. Walsh T., Teppler H., Donowitz G.R. et al. Caspofungin versus lipisomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-1402.
102. Wegner B., Baer P., Gauer S. et al. Caspofungin is less neptrotoxic than amphotericin B in vitro and ptedominantly damages distal renal tubular cells. Nephrol Dial Transplant 2005; 20: 2971-2079.
103. Weig M., Klinker H., Bogner B.H. et al. Usefulness of PCR for diagnosis of Pneumocystis carinii pneumonia in different patient groups. J Clin Microbiol 1997; 35(6): 1445-1449.
104. Wingard J.R., Kubilis P., Lee L. et al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven of aspergillosis. Clin Infect Dis 1999; 29: 1402-1407.
105. Wu G., Vilchez R.A., Eidelman B., Fung J., Kormos R., Kusne S. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis. 2002; 4(4): 183-188.
106. Yamada K., Shrier D.A., Rubio A. et al. Imaging findings in intracranial aspergillosis. Acad Radiol 2002; 9(2): 163-171.
Review
For citations:
Prokopenko E.I. Systemic mycoses in renal transplant recipients. Nephrology and Dialysis. 2006;8(1):6-15. (In Russ.)
Views:
12
Email this article 